Charles River Laboratories
Only 0.01% of drug candidates entering clinical trials reach the market. With Charles River supporting >80% of drugs approved by the FDA over the last five years, improve your odds, leverage our experience, and expedite your time to market.
- Our comprehensive portfolio supporting proteins, antibodies, vaccines, and cell and gene therapies includes:Cell Bank and Virus Manufacturing
- Biophysical, Molecular, and Genetic Characterization Services
- Biosafety and Viral Clearance Studies
- Bioactivity and Potency Testing
- Stability and QC Testing
- Cell and Gene Therapy CDMO Solutions
Contact us to learn how we can help to get your product to patients faster.